Patents Assigned to CellPrint IP Holding, LLC
  • Methods and compositions for affecting immunological responsiveness
    Patent number: 10369220
    Abstract: A method of treating a subject having a deficient immune response is described. The method includes administering a therapeutically effective amount of non-immune drug, or an analog or metabolite thereof, known to induce one or more autoimmune syndromes to the subject. Drugs known to induce one or more autoimmune syndromes, such as lupus-like syndromes, include immune checkpoint inhibitor blockers. Methods of identifying drugs capable of enhancing immunity are also described.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: August 6, 2019
    Assignee: CELLPRINT IP HOLDING, LLC
    Inventor: David R. Kaplan
  • METHODS AND COMPOSITIONS FOR AFFECTING IMMUNOLOGICAL RESPONSIVENESS
    Publication number: 20180092973
    Abstract: A method of treating a subject having a deficient immune response is described. The method includes administering a therapeutically effective amount of non-immune drug, or an analog or metabolite thereof, known to induce one or more autoimmune syndromes to the subject. Drugs known to induce one or more autoimmune syndromes, such as lupus-like syndromes, include immune checkpoint inhibitor blockers. Methods of identifying drugs capable of enhancing immunity are also described.
    Type: Application
    Filed: October 4, 2017
    Publication date: April 5, 2018
    Applicant: CellPrint IP Holding, LLC
    Inventor: David R. Kaplan
  • Method to assess patterns of molecular expression
    Patent number: 9383358
    Abstract: The invention is directed to a method to establish a biologically significant association of gene expression levels among two or more genes, the method comprising assaying a sample for expression levels of two or more genes and identifying statistically-significant associations using a correlation coefficient in the range of about 0.6 to about 1.0, wherein a correlation coefficient in that range signifies a biologically significant correlation.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: July 5, 2016
    Assignee: CellPrint IP Holding, LLC
    Inventor: David R. Kaplan